News und Analysen
Marcus & Millichap Brokers $150 Million Student Housing Portfolio Sale, Largest Ever in Illinois’ Champaign-Urbana Market
Marcus & Millichap (NYSE: MMI), a leading commercial real estate investment services firm with offices throughout the United States and Canada, today announced it has brokered the $150 million sale
PGT Innovations, Inc. to Release First Quarter 2022 Results and Host Conference Call on Thursday, May 12, 2022
PGT Innovations, Inc. (NYSE:PGTI) will release its financial results and host a conference call on Thursday, May 12, 2022, to discuss the company's first quarter 2022 results as well as other
New SBA Business Development Officer Joins First Internet Bank
First Internet Bank announced today that Genevieve Lua has joined its growing Small Business Administration (SBA) Lending team as a Vice President, Business Development Officer.
“Genevieve’s
Hardman & Co: Q&A on Oakley Capital Investments Ltd: Proving the pudding: a sustainable growth model'
San Juan Basin Royalty Trust Declares Cash Distribution for April 2022
PNC Bank, National Association, as the trustee (the “Trustee”) of the San Juan Basin Royalty Trust (the “Trust”) (NYSE: SJT), today declared a monthly cash distribution to the holders (the “Unit
Simulations Plus to Present at the Berenberg Discover AI Seminar
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be
Piper Sandler Companies to Hold Management Conference Call to Discuss First Quarter 2022 Results
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, will release its first quarter 2022 financial results prior to the opening of the market on Friday, April 29, 2022. The earnings
Elys Game Technology Reports Full-Year Audited 2021 Results
Elys Game Technology, Corp. (“Elys” or the “Company”)(Nasdaq:ELYS), an interactive gaming and sports betting technology company, today announced the financial results for the fiscal year ended
Aurinia Announces Year-Two Commitment to Patient Navigation Grant Program to Address Barriers for Individuals Living with Lupus and Lupus Nephritis
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today, affirmed its commitment to individuals living with the systemic lupus erythematosus (SLE) and lupus nephritis (LN)
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Stagecoach Group plc
Navidea Biopharmaceuticals Announces the Notice of Allowance for U.S. Patent Application for Diagnosis and Treatment of Leishmaniasis
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today
PNE AG: Additional wind park for own portfolio put into operation
DGAP-News: Digital publisher Axel Springer awarded 1st place in the prestigious SAMS Award 2022
Hardman & Co Research: Tissue Regenix (TRX) On pathway to sustainability
DGAP-News: SFC Energy signs 'Make in India' Agreement and launches EFOY Hydrogen Platform with its Cooperation Partner FC TecNrgy in India
Jack in the Box Announces Q2 2022 Earnings Webcast
Jack in the Box, Inc. (NASDAQ: JACK) announces the following event:
What:
JACK Q2 2022 Earnings Webcast
When:
Thursday, May 26 at 10:30 a.m. EDT
Orascom Development Holding AG: Publication of the Convocation to the Annual General Meeting 2022
GAMCO Expects to Report Diluted EPS for the First Quarter 2022 of $0.64 to $0.68 Per Share
GAMCO Investors, Inc. (“GAMCO”) (NYSE: GBL) announced today that it expects to report first quarter 2022 diluted earnings in the range of $0.64 to $0.68 per share versus $0.59 per share for the
Wish to Announce First Quarter 2022 Results on May 5, 2022
ContextLogic Inc. (d/b/a Wish) (NASDAQ: WISH), one of the world’s largest mobile ecommerce platforms, today announced it will report its first quarter 2022 financial results after the market close
Navidea Biopharmaceuticals Announces the Regulatory Approval of Lymphoaim in India
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today